LXEO – lexeo therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target lowered by analysts at Chardan Capital from $25.00 to $22.00. They now have a "buy" rating on the stock.
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study [Yahoo! Finance]
Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: Otero Jose Manuel
Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: Robertson Jenny
Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: See Tai Sandi
Form 8-K Lexeo Therapeutics, Inc. For: Apr 07
Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: Townsend Richard Nolan
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.